Ursula Reichenpfader

710 total citations
17 papers, 482 citations indexed

About

Ursula Reichenpfader is a scholar working on Pharmacology, Experimental and Cognitive Psychology and Psychiatry and Mental health. According to data from OpenAlex, Ursula Reichenpfader has authored 17 papers receiving a total of 482 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pharmacology, 5 papers in Experimental and Cognitive Psychology and 5 papers in Psychiatry and Mental health. Recurrent topics in Ursula Reichenpfader's work include Treatment of Major Depression (10 papers), Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (4 papers) and Bipolar Disorder and Treatment (3 papers). Ursula Reichenpfader is often cited by papers focused on Treatment of Major Depression (10 papers), Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (4 papers) and Bipolar Disorder and Treatment (3 papers). Ursula Reichenpfader collaborates with scholars based in United States, Austria and Sweden. Ursula Reichenpfader's co-authors include Bradley N. Gaynes, Gerald Gartlehner, Megan Van Noord, Linda J Lux, Laura C Morgan, Richard A. Hansen, Siw Carlfjord, Per Nilsén, Kylie Thaler and Patricia Thieda and has published in prestigious journals such as SHILAP Revista de lepidopterología, Annals of Internal Medicine and Drug Safety.

In The Last Decade

Ursula Reichenpfader

14 papers receiving 459 citations

Peers

Ursula Reichenpfader
Anne Timm Denmark
Nikhil Nihalani United States
Michael Yingling United States
S. Troy France
Ursula Reichenpfader
Citations per year, relative to Ursula Reichenpfader Ursula Reichenpfader (= 1×) peers L. Agüera

Countries citing papers authored by Ursula Reichenpfader

Since Specialization
Citations

This map shows the geographic impact of Ursula Reichenpfader's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ursula Reichenpfader with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ursula Reichenpfader more than expected).

Fields of papers citing papers by Ursula Reichenpfader

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ursula Reichenpfader. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ursula Reichenpfader. The network helps show where Ursula Reichenpfader may publish in the future.

Co-authorship network of co-authors of Ursula Reichenpfader

This figure shows the co-authorship network connecting the top 25 collaborators of Ursula Reichenpfader. A scholar is included among the top collaborators of Ursula Reichenpfader based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ursula Reichenpfader. Ursula Reichenpfader is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Reichenpfader, Ursula, Anette Wickström, Madeleine Abrandt Dahlgren, & Siw Carlfjord. (2019). ‘In the hospital all is taken care of’: a practice‐theoretical approach to understand patients’ medication use. Sociology of Health & Illness. 42(1). 50–64. 1 indexed citations
2.
Reichenpfader, Ursula, Anette Wickström, Per Nilsén, Madeleine Abrandt Dahlgren, & Siw Carlfjord. (2018). Medi(c)ation Work in the Emergency Department: Making Standardized Practice Work. SHILAP Revista de lepidopterología. 8(2). e2298–e2298. 2 indexed citations
3.
Reichenpfader, Ursula, Anette Wickström, Madeleine Abrandt Dahlgren, Per Nilsén, & Siw Carlfjord. (2018). ‘Our surgeons want this to be short and simple’: practices of in-hospital medication review as coordinated sociomaterial actions. Studies in Continuing Education. 40(3). 323–336. 1 indexed citations
4.
Reichenpfader, Ursula, Siw Carlfjord, & Per Nilsén. (2015). Leadership in evidence-based practice: a systematic review. Leadership in health services. 28(4). 298–316. 76 indexed citations
6.
Nußbaumer, Barbara, Laura C Morgan, Ursula Reichenpfader, et al.. (2014). Comparative Efficacy and Risk of Harms of Immediate- versus Extended-Release Second-Generation Antidepressants: A Systematic Review with Network Meta-Analysis. CNS Drugs. 28(8). 699–712. 15 indexed citations
7.
Reichenpfader, Ursula, Gerald Gartlehner, Laura C Morgan, et al.. (2013). Sexual Dysfunction associated with Second-Generation Antidepressants in Patients with Major Depressive Disorder: Results from a Systematic Review with Network Meta-Analysis. Drug Safety. 37(1). 19–31. 91 indexed citations
8.
Reichenpfader, Ursula, Kylie Thaler, Anke Richter, Patricia Thieda, & Gerald Gartlehner. (2012). Klinische Ergebnisse, gesundheitsbezogene Lebensqualität und Kosten-Effektivität eines 6-monatigen Programms zur Lebensstilmodifikation bei Personen mit erhöhtem kardioväskularen Risiko in Niederösterreich. Wiener Medizinische Wochenschrift. 162(15-16). 321–329.
9.
Gartlehner, Gerald, Richard A. Hansen, Laura C Morgan, et al.. (2011). Comparative Benefits and Harms of Second-Generation Antidepressants for Treating Major Depressive Disorder. Annals of Internal Medicine. 9 indexed citations
10.
Gartlehner, Gerald, Richard A. Hansen, Laura C Morgan, et al.. (2011). Comparative Benefits and Harms of Second-Generation Antidepressants for Treating Major Depressive Disorder. Annals of Internal Medicine. 155(11). 772–785. 260 indexed citations
11.
Gartlehner, Gerald, Richard A. Hansen, Ursula Reichenpfader, et al.. (2011). Characteristics of excluded studies for poor quality. 1 indexed citations
12.
Gartlehner, Gerald, Richard A. Hansen, Ursula Reichenpfader, et al.. (2011). Drug Class Review: Second-Generation Antidepressants: Final Update 5 Report [Internet]. 2 indexed citations
13.
Noord, Megan Van, Gerald Gartlehner, Richard A. Hansen, et al.. (2011). Immediate-release and extended-release formulations of second-generation antidepressants for the treatment of major depressive disorder in adults. European Psychiatry. 26(S2). 1289–1289.
14.
Gartlehner, Gerald, Richard A. Hansen, Laura C Morgan, et al.. (2011). Second-Generation Antidepressants in the Pharmacologic Treatment of Adult Depression. 6 indexed citations
15.
Gartlehner, Gerald, Richard A. Hansen, Ursula Reichenpfader, et al.. (2011). Drug Class Review: Second-Generation Antidepressants. 4 indexed citations
16.
Thaler, Kylie, Gerald Gartlehner, Richard A. Hansen, et al.. (2011). The comparative efficacy of second-generation antidepressants for the accompanying symptoms of depression: a systematic review. European Psychiatry. 26(S2). 697–697. 2 indexed citations
17.
Gartlehner, Gerald, Ursula Reichenpfader, Christina Kien, et al.. (2011). Drug Class Review: Second-Generation Antidepressants: Final Update 5 Report. Europe PMC (PubMed Central). 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026